China To Reimburse Biologics Under Five-Year Plan, Push Domestic Development
This article was originally published in PharmAsia News
Executive Summary
China’s biopharmaceutical industry is expected to grow annually 20% through 2015, according to the newly released Biologics Five-Year Plan by China’s State Council.